Overview

A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential Hypertension

Status:
Completed

Trial end date:
2014-02-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to Evaluate the Antihypertensive efficacy of Fimasartan 30 mg during 24 hours in Patients with Mild to Moderate Essential Hypertension

Phase:

Phase 2

Details

Lead Sponsor:

Boryung Pharmaceutical Co., Ltd

Collaborators:

Asan Medical Center
Chonnam National University Hospital
Inje University
Kyungpook National University
Kyungpook National University Hospital
Seoul National University Bundang Hospital
Seoul National University Hospital

Treatments:

Antihypertensive Agents
Valsartan